Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

6. Glycemic Targets: Standards of Medical Care in Diabetes—2020

Diabetes Care (2019) Vol. 43, Iss. Supplement_1, pp. S66-S76
Open Access | Times Cited: 688

Showing 1-25 of 688 citing articles:

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
Dawn Kleindorfer, Amytis Towfighi, Seemant Chaturvedi, et al.
Stroke (2021) Vol. 52, Iss. 7
Open Access | Times Cited: 1994
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
R. I. G. Holt, J. Hans DeVries, Amy Hess-Fischl, et al.
Diabetes Care (2021) Vol. 44, Iss. 11, pp. 2589-2625
Open Access | Times Cited: 433
A deep learning system for detecting diabetic retinopathy across the disease spectrum
Ling Dai, Liang Wu, Huating Li, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 392
The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
R. I. G. Holt, J. Hans DeVries, Amy Hess-Fischl, et al.
Diabetologia (2021) Vol. 64, Iss. 12, pp. 2609-2652
Open Access | Times Cited: 241
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
Sue A. Brown, Gregory P. Forlenza, Bruce W. Bode, et al.
Diabetes Care (2021) Vol. 44, Iss. 7, pp. 1630-1640
Open Access | Times Cited: 193
Ten things to know about ten cardiovascular disease risk factors
Harold Bays, Pam R. Taub, Elizabeth Epstein, et al.
American Journal of Preventive Cardiology (2021) Vol. 5, pp. 100149-100149
Open Access | Times Cited: 172
Association of a Healthy Lifestyle With All-Cause and Cause-Specific Mortality Among Individuals With Type 2 Diabetes: A Prospective Study in UK Biobank
Han Han, Yaying Cao, Chengwu Feng, et al.
Diabetes Care (2021) Vol. 45, Iss. 2, pp. 319-329
Open Access | Times Cited: 153
Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study
Ronan Roussel, Jean‐Pierre Riveline, Éric Vicaut, et al.
Diabetes Care (2021) Vol. 44, Iss. 6, pp. 1368-1376
Open Access | Times Cited: 114
Novel therapies with precision mechanisms for type 2 diabetes mellitus
Leigh Perreault, Jay S. Skyler, Julio Rosenstock
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 6, pp. 364-377
Closed Access | Times Cited: 111
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial
Aditi R. Saxena, Donal Gorman, Ryan M. Esquejo, et al.
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 1079-1087
Closed Access | Times Cited: 104
Subcutaneous weekly semaglutide with automated insulin delivery in type 1 diabetes: a double-blind, randomized, crossover trial
Melissa‐Rosina Pasqua, Michael A. Tsoukas, Alessandra Kobayati, et al.
Nature Medicine (2025)
Open Access | Times Cited: 2
Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology
Jordan E. Pinsker, Lars Müller, Alexandra Constantin, et al.
Diabetes Technology & Therapeutics (2020) Vol. 23, Iss. 2, pp. 120-127
Open Access | Times Cited: 115
The Digital/Virtual Diabetes Clinic: The Future Is Now—Recommendations from an International Panel on Diabetes Digital Technologies Introduction
Moshe Phillip, Richard M. Bergenstal, Kelly L. Close, et al.
Diabetes Technology & Therapeutics (2020) Vol. 23, Iss. 2, pp. 146-154
Open Access | Times Cited: 106
Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent
M. Larissa Avilés‐Santa, Alberto Monroig-Rivera, Alvin Soto-Soto, et al.
Current Diabetes Reports (2020) Vol. 20, Iss. 11
Open Access | Times Cited: 95
Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
Marco Castellana, Claudia Parisi, Sergio Di Molfetta, et al.
BMJ Open Diabetes Research & Care (2020) Vol. 8, Iss. 1, pp. e001092-e001092
Open Access | Times Cited: 72
Protein glycation – biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine
Naila Rabbani, Paul J. Thornalley
Redox Biology (2021) Vol. 42, pp. 101920-101920
Open Access | Times Cited: 72
Hypoglycemia unawareness and autonomic dysfunction in diabetes: Lessons learned and roles of diabetes technologies
Yu Kuei Lin, Simon J. Fisher, Rodica Pop‐Busui
Journal of Diabetes Investigation (2020) Vol. 11, Iss. 6, pp. 1388-1402
Open Access | Times Cited: 71
Efficacy and safety of once‐weekly semaglutide versus once‐daily sitagliptin as add‐on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30‐week, double‐blind, phase 3a, randomized trial
Linong Ji, Xiaolin Dong, Yiming Li, et al.
Diabetes Obesity and Metabolism (2020) Vol. 23, Iss. 2, pp. 404-414
Open Access | Times Cited: 70
A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes
Andreas Andersen, Filip K. Knop, Tina Vilsbøll
Drugs (2021) Vol. 81, Iss. 9, pp. 1003-1030
Open Access | Times Cited: 69
New strategies to improve clinical outcomes for diabetic kidney disease
Thomas Först, Chantal Mathieu, Francesco Giorgino, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 66
Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial
Mads N. Thomsen, Mads J. Skytte, Amirsalar Samkani, et al.
Diabetologia (2022) Vol. 65, Iss. 3, pp. 506-517
Open Access | Times Cited: 63
Risk Factors for Prolonged Mechanical Ventilation and Weaning Failure: A Systematic Review
Franziska Trudzinski, Benjamin Neetz, Florian Bornitz, et al.
Respiration (2022) Vol. 101, Iss. 10, pp. 959-969
Open Access | Times Cited: 60
Evaluation of glycemic control and related factors among outpatients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a cross-sectional study
Rodas Getachew Abera, Eyouel Shimeles Demesse, Wako Dedecha Boko
BMC Endocrine Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 56
Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis
Anders L. Carlson, Timothy D. Daniel, Andrea Desantis, et al.
BMJ Open Diabetes Research & Care (2022) Vol. 10, Iss. 1, pp. e002590-e002590
Open Access | Times Cited: 48
Review of present method of glucose from human blood and body fluids assessment
Klara Fiedorova, Martin Augustýnek, Jan Kubíček, et al.
Biosensors and Bioelectronics (2022) Vol. 211, pp. 114348-114348
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top